Trends in Influenza-Associated Lower Respiratory Tract Infection Burden and Influenza Vaccination Coverage among Adults Aged >=55 Years in China, 1990-2023
liu, m.; Chen, R.
Show abstract
ABSTRACT Background Influenza-associated lower respiratory tract infections (LRTI) impose substantial disease burden on older populations globally. While China has experienced rapid aging, comprehensive assessment of long-term trends in influenza-associated LRTI burden and vaccination coverage among adults aged [≥]55 years remains limited. Methods We extracted age-standardized mortality and disability-adjusted life years (DALYs) rates of influenza-associated LRTI among Chinese adults aged [≥]55 years from the Global Burden of Disease Study 2023 (GBD 2023). Estimated annual percentage change (EAPC) and age-period-cohort (APC) models were employed to analyze long-term trends (1990-2023). Using the China Health and Retirement Longitudinal Study 2020 (CHARLS 2020, n=13,815), we performed multivariable logistic regression to identify factors associated with influenza vaccination uptake. Spearman correlation assessed ecological associations between GBD age-specific mortality rates and CHARLS vaccination coverage across nine age groups. Results Age-standardized mortality rates declined from 4.09 to 0.31 per 100,000 (EAPC=-8.02%, 95%CI: -9.08% to -6.95%), and DALYs rates from 177.63 to 6.06 per 100,000 (EAPC=-10.67%), representing >96% reductions from 1990 to 2023. Deaths dropped sharply by 59.6% in 2020, consistent with protective effects of non-pharmaceutical interventions during COVID-19. The [≥]85-year age group showed the slowest improvement (EAPC=-5.63%). Influenza vaccination coverage in CHARLS 2020 was only 15.1%. Older age ([≥]85 years: OR=0.65, 95%CI: 0.46-0.92) and higher educational attainment (college or above: OR=0.34, 95%CI: 0.20-0.56) were independently associated with lower vaccination rates, though the small sample size in the highest education group (n=68) warrants cautious interpretation. Ecological analysis revealed a significant negative correlation between GBD mortality rates and CHARLS vaccination coverage (r=-0.700, p=0.036, n=9 age groups), indicating a "protection mismatch" phenomenon. Raising vaccination coverage to 75% (WHO target) could prevent approximately 2,041 deaths annually under moderate vaccine efficacy assumptions, with [≥]75-year-olds contributing 82.7% of preventable deaths. Conclusions Influenza-associated LRTI burden has declined substantially among Chinese adults aged [≥]55 years, but improvement is slowest in the oldest age groups. Vaccination coverage remains critically insufficient with a persistent "protection mismatch" where those at highest mortality risk have lowest coverage. Adults aged [≥]75 years face a "triple vulnerability" of high mortality, low vaccination coverage, and high COPD comorbidity prevalence, and should be prioritized for vaccination to maximize preventable mortality benefits.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Information nudges for influenza vaccination: Evidence from a large-scale cluster-randomized controlled trial 93%
- Impact of a city-wide school-located influenza vaccination program over four years on vaccination coverage, school absences, and laboratory-confirmed influenza: a prospective matched cohort study 91%
- Pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: a retrospective record linkage cohort study 91%
Similar papers in this journal
- Impact of CoronaVac on Covid-19 outcomes of elderly adults in a large and socially unequal Brazilian city: A target trial emulation study 93%
- Averted mortality by COVID-19 vaccination in Belgium between 2021 and 2023 93%
- Assessment of the impact of the Vaccine Pass Policy on COVID-19 vaccine hesitancy and uptake among Chinese adults in Hong Kong 93%
Similar papers in this journal
- Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalization among Finnish elderly and chronically ill – An interim analysis of a nationwide cohort study 93%
- Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada: impact of variant replacement and waning protection during 10-month follow-up 93%
- COVID-19 vaccine effectiveness against laboratory confirmed symptomatic SARS-CoV-2 infection, COVID-19 related hospitalizations and deaths, among individuals aged 65 years or more in Portugal: a cohort study based on data-linkage of national registries February-September 2021 92%
Similar papers in this journal
- Evaluating seasonal variations in human contact patterns and their impact on the transmission of respiratory infectious diseases 91%
- mRNA COVID-19 vaccine effectiveness against SARS-CoV-2 infection in a prospective community cohort, rural Wisconsin, November 2020-December 2021 90%
- The REinfection in COVID-19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers 90%
Similar papers in this journal
- Vaccine Rollout Strategies: The Case for Vaccinating Essential Workers Early 90%
- Exposure to the 1959-1961 Chinese Famine and Risk of Non-Communicable Diseases in Later Life: a Life Course Perspective 90%
- Predicting Mobile Health Clinic Utilization for COVID-19 Vaccination in South Carolina: A Statistical Framework for Strategic Resource Allocation 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.